title: [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
authors.forename: L N
authors.initials: LN
authors.lastname: Shishkina
authors.forename: V E
authors.initials: VE
authors.lastname: Nebol'sin
authors.forename: M O
authors.initials: MO
authors.lastname: Skarnovich
authors.forename: A S
authors.initials: AS
authors.lastname: Kabanov
authors.forename: A A
authors.initials: AA
authors.lastname: Sergeev
authors.forename: U B
authors.initials: UB
authors.lastname: Erdyneeva
authors.forename: O A
authors.initials: OA
authors.lastname: Serova
authors.forename: O K
authors.initials: OK
authors.lastname: Demina
authors.forename: A P
authors.initials: AP
authors.lastname: Agafonov
authors.forename: E A
authors.initials: EA
authors.lastname: Stavskiĭ
authors.forename: I G
authors.initials: IG
authors.lastname: Drozdov
mesh_terms: D000577:Amides / Q000627:therapeutic use*; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002208:Caproates; D003998:Dicarboxylic Acids / Q000627:therapeutic use*; D005260:Female; D007093:Imidazoles / Q000627:therapeutic use*; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects* / Q000502:physiology; D053122:Influenza A Virus, H3N2 Subtype / Q000187:drug effects; D008168:Lung / Q000187:drug effects / Q000821:virology; D051379:Mice; D008807:Mice, Inbred BALB C; D009976:Orthomyxoviridae Infections / Q000188:drug therapy* / Q000401:mortality / Q000821:virology; D053139:Oseltamivir / Q000627:therapeutic use; D012299:Rimantadine / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000577:Amides; D000998:Antiviral Agents; D002208:Caproates; D003998:Dicarboxylic Acids; D007093:Imidazoles; D012299:Rimantadine; D053139:Oseltamivir; C539419:pentanedioic acid imidazolyl ethanamide